BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25800958)

  • 1. Facilitation of blood donation amongst haemochromatosis patients.
    Marrow B; Clarkson J; Chapman CE; Masson S
    Transfus Med; 2015 Aug; 25(4):239-42. PubMed ID: 25800958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide policies on haemochromatosis and blood donation: a survey among blood services.
    Pauwels NS; De Buck E; Compernolle V; Vandekerckhove P
    Vox Sang; 2013 Aug; 105(2):121-8. PubMed ID: 23663183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre.
    Stefashyna O; Stern M; Infanti L; Holbro A; Tichelli A; Buser A; O'Meara A
    Vox Sang; 2014 Feb; 106(2):111-7. PubMed ID: 23992555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients.
    Pennings G
    J Med Ethics; 2005 Feb; 31(2):69-72. PubMed ID: 15681668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomy patterns in haemochromatosis patients and their contribution to the blood supply.
    Walkden D; Badami K
    N Z Med J; 2012 Jul; 125(1358):29-34. PubMed ID: 22864154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood donation by healthy individuals with haemochromatosis.
    Blacklock HA; Dewse M; Bollard C; Hudson P; Barnhill D; Jackson S
    N Z Med J; 2000 Mar; 113(1105):77-8. PubMed ID: 10855583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemochromatosis: evaluating the effectiveness of a novel patient self-management approach to venesection as blood donation.
    Mishra S; Sim D; Flanagan P
    N Z Med J; 2017 Jun; 130(1457):26-33. PubMed ID: 28617785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Easy come, easy go. Retention of blood donors.
    van Dongen A
    Transfus Med; 2015 Aug; 25(4):227-33. PubMed ID: 26399971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron saturation of ferritin in the course of phlebotomy treatment in patients with haemochromatosis.
    ten Kate J; Marell K; Huizinga R; Kreeftenberg H; van Deursen C
    Clin Chem Lab Med; 1999 Aug; 37(8):827-30. PubMed ID: 10536932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting personal with blood donors - the rationale for, methodology of and an overview of participants in the UK blood donor survey.
    Davison KL; Reynolds CA; Andrews N; Brailsford SR;
    Transfus Med; 2015 Aug; 25(4):265-75. PubMed ID: 26337860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and testing of promotion materials on tissue and organ donation.
    Brkljacic T; Feric I; Rihtar S
    Croat Med J; 2003 Apr; 44(2):225-33. PubMed ID: 12698516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced exercise capacity in genetic haemochromatosis.
    Davidsen ES; Liseth K; Omvik P; Hervig T; Gerdts E
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):470-5. PubMed ID: 17568251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of prospective donors: what do they expect from a homepage of a blood transfusion service?
    Moog R; Fourné K
    Transfus Med; 2007 Aug; 17(4):279-84. PubMed ID: 17680953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemochromatosis patients as voluntary blood donors.
    Power TE; Adams PC
    Can J Gastroenterol; 2004 Jun; 18(6):393-6. PubMed ID: 15190395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemochromatosis subjects as allogeneic blood donors: a prospective study.
    Leitman SF; Browning JN; Yau YY; Mason G; Klein HG; Conry-Cantilena C; Bolan CD
    Transfusion; 2003 Nov; 43(11):1538-44. PubMed ID: 14617312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center.
    Gribble DM; Chaffin DJ; Bryant BJ
    Immunohematology; 2009; 25(4):170-3. PubMed ID: 20406025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring donor safety: is venesecting therapeutic donors to haemoglobin levels below Blood Service guidelines safe?
    Lim Z; Bentley P; Olynyk JK
    Vox Sang; 2020 May; 115(4):288-292. PubMed ID: 32080874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. role of altruistic behavior, empathetic concern, and social responsibility motivation in blood donation behavior.
    Steele WR; Schreiber GB; Guiltinan A; Nass C; Glynn SA; Wright DJ; Kessler D; Schlumpf KS; Tu Y; Smith JW; Garratty G;
    Transfusion; 2008 Jan; 48(1):43-54. PubMed ID: 17894795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.